Cadence and NVIDIA Unveil Groundbreaking Generative AI and Accelerated Compute-Driven Innovations
Cadence Design Systems, Inc. announces an expansion of its collaboration with NVIDIA, unveiling transformative solutions like the Cadence Reality Digital Twin Platform and generative AI for drug discovery. The platform accelerates data center design with AI and physics-based simulation, improving energy efficiency by up to 30%. The integration with NVIDIA Omniverse enhances data center workflows by 30X. The collaboration also supercharges drug discovery with NVIDIA BioNeMo, enabling faster therapeutic design and results. The partnership aims to revolutionize data center design and drug discovery, leading the AI revolution.
The integration of Cadence Reality Digital Twin Platform with NVIDIA Omniverse represents a significant leap in the realm of data center optimization. The ability to simulate and optimize data centers with a projected 30% improvement in energy efficiency could be a game-changer for industries reliant on large-scale computing. This technology allows for predictive modeling of data center operations, which could lead to substantial cost savings and a reduction in carbon footprint, aligning with global sustainability goals.
Moreover, the acceleration of design workflows by 30X due to this integration indicates a substantial increase in productivity, which could reduce time-to-market for new data center designs. This efficiency gain is not just a technical milestone but also a potential financial lever, as faster design cycles can lead to earlier revenue generation for new facilities.
The fusion of Cadence's Orion molecular design platform with NVIDIA's BioNeMo is poised to disrupt the pharmaceutical industry's approach to drug discovery. The enhanced platform's capacity to accelerate the generation and assessment of design hypotheses for a wide range of therapeutics is noteworthy. The emphasis on using generative AI to streamline this process could potentially shrink the drug development timeline, which traditionally spans several years.
Access to on-demand GPU resources at an unprecedented scale is a critical factor for pharmaceutical companies. This access facilitates more complex simulations and faster hypothesis testing, which can lead to quicker identification of viable drug candidates. The impact on the stock market could be reflected in the valuation of pharmaceutical companies that adopt this technology, as it may signal a competitive advantage in the race to bring new drugs to market.
The projected 30% increase in data center energy efficiency due to the Cadence Reality Digital Twin Platform could have a profound impact on the industry's sustainability efforts. Data centers are known for their substantial energy consumption and any technology that can significantly reduce this is of great importance. From an investor's perspective, companies that adopt such energy-efficient technologies may not only benefit from reduced operational costs but also from enhanced corporate responsibility profiles.
As investors are increasingly considering environmental, social and governance (ESG) factors in their investment decisions, advancements in energy efficiency can make companies more attractive investments. This is especially relevant in an era where regulatory pressures and consumer sentiment are driving companies towards greener solutions.
03/18/2024 - 06:00 PM
Cadence Reality Digital Twin Platform integrated with NVIDIA Omniverse and Orion molecular design platform accelerated with NVIDIA BioNeMo will transform the future of design
SAN JOSE, Calif. --(BUSINESS WIRE)--
Cadence Design Systems, Inc. (Nasdaq: CDNS) today announced an expansion of its multi-year collaboration with NVIDIA across EDA, system design and analysis, digital biology and AI with the unveiling of two transformative solutions to reinvent design using accelerated computing and generative AI.
First, the new Cadence® Reality™ Digital Twin Platform is the industry’s pioneering comprehensive digital twin solution to facilitate speed-of-light acceleration of the design, simulation and optimization of data centers across multiple industries. The platform virtualizes the entire data center and uses AI, high-performance computing (HPC) and physics-based simulation to significantly improve data center energy efficiency by up to 30% .
The Cadence Reality platform’s integration with NVIDIA Omniverse™ brings OpenUSD data interoperability and physically based rendering to the digital twin solution—helping accelerate data center design and simulation workflows by 30X.
Second, the companies are collaborating on generative AI to dramatically accelerate approaches to drug discovery. Cadence’s cloud-native molecular design platform Orion® will now be supercharged with NVIDIA’s generative AI tool, NVIDIA BioNeMo™ , and NVIDIA microservices for drug discovery to broaden therapeutic design capabilities and shorten time to trusted results. The collaboration brings together decades of expertise in scientific software and accelerated computing from the two companies to deliver transformative approaches to drug discovery. Accelerated by on-demand GPU access at an unprecedented scale, pharmaceutical companies can quickly and reliably generate and assess design hypotheses across a range of therapeutic modalities, including biologics, peptides and small molecules.
“The broadening collaboration between NVIDIA and Cadence is having a transformative impact on everything from data center design to drug discovery,” said Dr. Anirudh Devgan, president and CEO, Cadence. “As AI rapidly becomes a keystone technology driving data center and data center workload expansion, the Cadence Reality Digital Twin Platform integration with NVIDIA Omniverse will optimize every aspect of data center design and operations, use energy more efficiently, and pave the way for a more efficient, resilient, and environmentally friendly future. Our groundbreaking efforts with NVIDIA to integrate BioNeMo with our industry-leading Orion molecular design tools hold great promise for unlocking new ideas and transforming the future of therapeutics and drug discovery. Together, NVIDIA and Cadence are leading the AI revolution.”
“Digital twins will transform manufacturing, drug discovery and countless other industries,” said Jensen Huang, founder and CEO of NVIDIA. “Using NVIDIA Omniverse and generative AI technologies, Cadence can deliver simulation and digitalization technologies to benefit individuals, companies and societies in ways we have yet to imagine.”
Growing Importance of Digital Twin Technology
Digital twin technology is increasingly becoming critical to designers and operators of complex data center systems in the AI era as through creating a virtual replica of a physical system, it can use real-time data to simulate its behavior, performance and interactions in various conditions. The Cadence Reality platform provides visibility across the entire value chain, enabling data center designers and operators to simulate the performance of integrated liquid and air-cooling systems, visualize the performance of data centers and plan for what-if scenarios.
The company’s collaboration with NVIDIA also expands the capabilities of the Orion drug discovery platform by providing key capabilities, including access to BioNeMo models for structure prediction, small molecule generation and molecular property prediction. Molecules generated with BioNeMo may then be profiled and iteratively enhanced and designed with Orion tools.
Today’s announcements build upon Cadence and NVIDIA’s long-standing collaboration in areas such as:
AI-driven digital and custom IC design, including PPA, schedule and cost reduction of NVIDIA GPUs with Cadence Innovus™ and Cadence Cerebrus™ solutions
Over 20 years of partnership in hardware and software verification, including Palladium®, Protium™ , and now Cadence Verisium™ technologies
System design and analysis, including GPU-optimized Cadence Fidelity™ CFD Software and the revolutionary Cadence Millennium™ Enterprise Multiphysics Platform
These announcements also open a new chapter of Cadence’s Intelligent System Design™ strategy to help customers develop differentiated products across a wide range of industries and market verticals.
About Cadence
Cadence is a pivotal leader in electronic systems design, building upon more than 30 years of computational software expertise. The company applies its underlying Intelligent System Design strategy to deliver software, hardware and IP that turn design concepts into reality. Cadence customers are the world’s most innovative companies, delivering extraordinary electronic products from chips to boards to complete systems for the most dynamic market applications, including hyperscale computing, 5G communications, automotive, mobile, aerospace, consumer, industrial and healthcare. For nine years in a row, Fortune magazine named Cadence one of the 100 Best Companies to Work For. Learn more at cadence.com .
© 2024 Cadence Design Systems, Inc. All rights reserved worldwide. Cadence, the Cadence logo and the other Cadence marks found at www.cadence.com/go/trademarks are trademarks or registered trademarks of Cadence Design Systems, Inc. All other trademarks are the property of their respective owners.
Category: Featured
View source version on businesswire.com: https://www.businesswire.com/news/home/20240318127116/en/
Cadence Newsroom
newsroom@cadence.com
Source: Cadence Design Systems, Inc.
What is the name of the company mentioned in the press release?
Cadence Design Systems, Inc.
What is the ticker symbol for Cadence Design Systems, Inc.?
What are the two transformative solutions unveiled in the collaboration between Cadence and NVIDIA?
The Cadence Reality Digital Twin Platform and generative AI for drug discovery.
How does the Cadence Reality Digital Twin Platform improve data center energy efficiency?
By up to 30% through AI, HPC, and physics-based simulation.
What does the integration with NVIDIA Omniverse bring to the Cadence Reality platform?
OpenUSD data interoperability and physically based rendering, accelerating data center design workflows by 30X.
What is the purpose of supercharging Cadence's Orion molecular design platform with NVIDIA BioNeMo?
To accelerate drug discovery approaches and broaden therapeutic design capabilities.
Who is the president and CEO of Cadence Design Systems, Inc.?
What is the goal of the collaboration between NVIDIA and Cadence according to Dr. Anirudh Devgan?
To optimize data center design and operations, use energy more efficiently, and transform the future of therapeutics and drug discovery.
According to Jensen Huang, what industries will be transformed by digital twins?
Manufacturing, drug discovery, and countless other industries.
What technology is increasingly critical to designers and operators of complex data center systems in the AI era?
